$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Efficacy and safety of sotoracib
2026-02-01 22:25:32
Check Details
Sotoraxib versus conventional chemotherapy: Comparison of two major strategies in lung cancer treatment
2026-02-01 22:25:32
Check Details
The problem of drug resistance to sotoraxib and its countermeasures and delay methods
2026-02-01 22:25:32
Check Details
What is the quality of the Laos Lucius version of the generic version of Brigatinib (Brigatinib), how to buy it, and how much does it cost?
2026-02-01 22:25:32
Check Details
How much will Brigatinib (Embry) cost after medical insurance reimbursement in 2024, and what are the reimbursement conditions?
2026-02-01 22:25:32
Check Details
A complete guide to using and purchasing the Lao version of the generic version of Brigatinib
2026-02-01 22:25:32
Check Details
How effective is brigatinib in treating brain metastasis of lung cancer?
2026-02-01 22:25:32
Check Details
Cabozantinib research and development background, market price and purchasing guide
2026-02-01 22:25:32
Check Details
How much does a box of generic cabozantinib cost, and how to buy the genuine product?
2026-02-01 22:25:32
Check Details
Who is cabozantinib suitable for and what are its advantages?
2026-02-01 22:25:32
Check Details
What are the side effects and hazards of the targeted drug cabozantinib, and how to deal with them?
2026-02-01 22:25:32
Check Details
Patients are highly satisfied with ritexitinib for the treatment of alopecia areata
2026-02-01 22:25:32
Check Details
1
2
...
1133
1134
1135
1136
1137
1138
1139
...
10224
10225
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
2
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
3
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
4
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
5
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
6
Ponatinib: A Third-Generation TKI Targeting BCR::ABL1 to Overcome Leukemia Drug Resistance
7
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
8
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
9
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
10
Eltrombopag Administration Timing and Alternative Therapy Guide
11
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
12
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use